Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma
PHASE3
RATIONALE: Imaging procedures, such as fludeoxyglucose F 18 (FDG)-PET/CT sc...
Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
PHASE3
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells...
Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)
PHASE1
The purpose of this study is to test any good or bad effects of the study d...
Status
Completed
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)